Alx Oncology Holdings Inc’s recently made public that its SVP, FINANCE AND CAO Pinto Shelly unloaded Company’s shares for reported $633.0 on Feb 19 ’25. In the deal valued at $1.15 per share,550 shares were sold. As a result of this transaction, Pinto Shelly now holds 87,352 shares worth roughly $87352.0.
Then, Pons Jaume sold 1,326 shares, generating $1,525 in total proceeds. Upon selling the shares at $1.15, the PRESIDENT & CSO now owns 579,388 shares.
Before that, Lettmann Jason sold 2,159 shares. Alx Oncology Holdings Inc shares valued at $2,483 were divested by the CHIEF EXECUTIVE OFFICER at a price of $1.15 per share. As a result of the transaction, Lettmann Jason now holds 170,270 shares, worth roughly $0.17 million.
Jefferies downgraded its Alx Oncology Holdings Inc [ALXO] rating to a Hold from a a Buy in a research note published on December 19, 2024; the price target was decreased to $2 from $12. A number of analysts have revised their coverage, including Stifel’s analysts, who decreased its forecast for the stock in early March from “a Buy” to “a Hold”. Jefferies also remained covering ALXO and has increased its forecast on December 08, 2023 with a “Buy” recommendation from previously “Hold” rating. Jefferies revised its rating on December 22, 2021. It rated ALXO as “a Hold” which previously was an “a Buy”.
Price Performance Review of ALXO
On Tuesday, Alx Oncology Holdings Inc [NASDAQ:ALXO] saw its stock fall -2.91% to $1.00. Over the last five days, the stock has lost -4.76%. Alx Oncology Holdings Inc shares have fallen nearly -40.12% since the year began. Nevertheless, the stocks have fallen -93.18% over the past one year. While a 52-week high of $17.83 was reached on 01/08/25, a 52-week low of $0.96 was recorded on 03/04/25. SMA at 50 days reached $1.4313, while 200 days put it at $3.4853.
Levels Of Support And Resistance For ALXO Stock
The 24-hour chart illustrates a support level at 0.9509, which if violated will result in even more drops to 0.9019. On the upside, there is a resistance level at 1.0445. A further resistance level may holdings at 1.0891. The Relative Strength Index (RSI) on the 14-day chart is 34.33, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0452, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 80.41%. Stochastics %K at 33.05% indicates the stock is a holding.
The most recent change occurred on September 30, 2021 when Stifel began covering the stock and recommended ‘”a Buy”‘ rating along with a $106 price target.
